Ultrastructure of Candida albicans pleomorphic forms: phase-contrast microscopy, scanning and transmission electron microscopy

• Autorzy: Staniszewska M. , Bondaryk M. , Siennicka K. , Kurzatkowski W.
• Języki publikacji: EN

Abstrakty

EN

A modified method of glutaraldeyde-osmium tetroxide fixation was adjusted to characterize the ultrastructure of Candida albicans pleomorphic forms, using phase-contrast microscopy, scanning electron microscopy and transmission electron microscopy. &e discovered morphological criteria defining the individual morphotypes are discussed in terms of mycological and histopathological diagnostics of candidiasis. &e relations are discussed between fungal pleomorphism, virulence and susceptibility of di!erent morphotypes to fungicides.

Słowa kluczowe

EN

ultrastructure; Candida albicans; pleomorphic form; scanning electron microscopy; transmission electron microscopy; diagnostics; morphotype

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2012
• Tom: 61
• Numer: 2
• Opis fizyczny: p.129-135,fig.,ref.

Twórcy

autor

Staniszewska M.

• National Institute of Public Health - National Institute of Hygiene, Chocimska 24, 00-791 Warsaw, Poland

autor

Bondaryk M.

autor

Siennicka K.

autor

Kurzatkowski W.

Bibliografia

• Barnet J.A. 2008. A history of research on yeasts 12: medical yeasts part I, Candida albicans. Yeast. 25: 385–417.
• Crampin H., K. Finley, M. Gerami-Nejad, H. Court, C. Gale, J. Berman and P. Sudbery. 2005. Candida albicans hyphae have a Spitzenkörper that is distinct from the polarisome found in yeast and pseudohyphae. J. Cell. Sci. 118: 2935–2947.
• Dignani M.C., J.S. Solomkin and E.J. Anaissie. 2003. Candida, pp. 195–239. In: Anaissie E.J., M.R. McGinnis and M.A. Pfaller (eds) Clinical Mycology. Churchill Livingstone, Philadelphia, USA.
• Kruppa M. 2009. Quorum sensing and Candida albicans. Mycoses. 52: 1–10.
• Kuryłowicz W., W. Kurzatkowski, W. Woznicka, H. Połowniak-Pracka, A. Paszkiewicz, J. Luba and J. Piorunowski. 1980. Atlas of the Ultrastructure of Penicillium Chrysogenum in the Course of Biosynthesis of Penicillin. Chemia. Warsaw.
• Kurzatkowski W., M. Staniszewska and S. Tyski. 2010. Damage of Candida albicans blastoconidia exposed to biocides. Mycoses. doi:10.1111/j.1439-0507.2010.01900.x
• Merson-Davies L.A. and F. Odds. 1989. A morphology index of characterization of cell shape in Candida albicans. J. Gen. Microbiol. 135: 3143–3152.
• Müller J. and W. Melchinger. 2006. Ultrastructural characters defining the terms ‘yeast cell’, ‘pseudonycelium’ and ‘true mycelium in Candida albicans. Mycoses. 49: 24–30.
• Ness F., V. Prouzet-Mauleon, A. Vieillemard, F. Lefebvre, T. Noël, M. Crouzet, F. Doignon and D. Thoraval. 2010. The Candida albicans Rgd1 is a RhoGAP protein involved in the control of filamentous growth. Fungal Genetics and Biology 47: 1001–1011.
• Netea M.G., G.D. Brown, B.J. Kullberg and N.A.R. Gow. 2008. An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 6: 67–78.
• Nguyen K.A., G. Zmeter, O. Claris and B. Kassai. 2011. Epidemiology of invasive Candida infection in a neonatal intensive care unitin France. Acta Paediatrica. DOI:10.1111/j. 1651-2227.2011.02514.x
• Noble S.M., S. French, L.A. Kohn, V. Chen and A.D. Johnson. 2010. Systematic Screens of Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat. Genet. 42: 590–598.
• Okawa Y., M. Miyauchi, S. Takahashi and H. Kobayashi. 2007. Comparison of pathogenicity of various Candida albicans and C. Stellatoidea strains. Biol. Pharm. Bull. 10: 1870–1873.
• Przyjałkowski W. 2006. Fungal infections of the central nervous system (in Polish). In: Dzierzanowska D. (ed). pp. 154–165. Zakazenia grzybicze – wybrane zagadnienia. α-medica Press, Bielsko-Biała.
• Raška M., J. Beláková, M. Krupka and E. Weigl. 2007. Candidiasis – do we need to fight or to tolerate the Candida fungus? Folia Microbiol. 52: 297–312.
• Salfelder K., T.R. de Liscano and E. Sauertaig. 1990. Atlas of Fungal Pathology. Kluwer Academic Publishing, Dordrecht, Boston, London.
• Staniszewska M., B. Rozbicka, A. Rajnisz, E. Bocian, E. Wasinska, B. Jakimiak, E. Röhm Rodowald, W. Kurzatkowski and S. Tyski. 2010. Susceptibility of Candida spp. Clinical isolates to antimycotics and disinfectans. Cent. Eur. J. Biol. 5: 821–826.
• Staniszewska M., M. Bondaryk and W. Kurzatkowski. 2011a. Morphotypes of Candida albicans. Phase-contrast microscopy. Mikologia lekarska. 18: 5–10.
• Staniszewska M., D. Rabczenko and W. Kurzatkowski. 2011b. Discrimination between the enzymatic activities of Candida albicans pleomorphic forms determined using the api® ZYM test. Mycoses. doi.10.1111/j.1439-0507.2010.02011.x
• Stradomska T.J. 2006. Metabolites detection in the diagnosis of systemic fungal infections (in Polish). pp. 71–78. In: D. Dzierzanowska (ed). Zakazenia grzybicze – wybrane zagadnienia. α-medica Press, Bielsko-Biała.
• Warzocha K. and I. Seferynska. 2006. Fungal infections in haematology (in Polish). pp. 137–153. In: D. Dzierzanowska (ed). Zaka zenia grzybicze – wybrane zagadnienia. α-medica Press, Bielsko-Biała.
• Woods G.L. and V. Schnadig. 2003. Histopathology of fungal infections. pp. 80–95. In: E.J. Anaissie, M.R. McGinnis and M.A. Pfaller (eds). Clinical Microbiology. Churchill Livingstone, Philadelphia.